國立虎尾科技大學 |

Pharmacological interventions for osteoporosis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmacological interventions for osteoporosis/ edited by Andy H. Choi, Sian Yik Lim.
其他作者:	Lim, Sian Yik.
出版者:	Singapore :Springer Nature Singapore : : 2023.,
面頁冊數:	x, 118 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Medicinal Chemistry. -
電子資源:	https://doi.org/10.1007/978-981-99-5826-9
ISBN:	9789819958269

Pharmacological interventions for osteoporosis
Pharmacological interventions for osteoporosis[electronic resource] /edited by Andy H. Choi, Sian Yik Lim. - Singapore :Springer Nature Singapore :2023. - x, 118 p. :ill., digital ;24 cm. - Tissue repair and reconstruction,2731-9199. - Tissue repair and reconstruction..

Bisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.

This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.

ISBN: 9789819958269

Standard No.: 10.1007/978-981-99-5826-9doiSubjects--Topical Terms:

668872
Medicinal Chemistry.

LC Class. No.: RC931.O73

Dewey Class. No.: 616.713061

Pharmacological interventions for osteoporosis
LDR:02246nam a2200337 a 4500 001 1117074
003 DE-He213
005 20230921200813.0
006 m d
007 cr nn 008maaau
008 240124s2023 si s 0 eng d
020 $a 9789819958269 $q (electronic bk.)
020 $a 9789819958252 $q (paper)
024 7 $a 10.1007/978-981-99-5826-9 $2 doi
035 $a 978-981-99-5826-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC931.O73
072 7 $a MQW $2 bicssc
072 7 $a TEC059000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 616.713061 $2 23
090 $a RC931.O73 $b P536 2023
245 1 0 $a Pharmacological interventions for osteoporosis $h [electronic resource] / $c edited by Andy H. Choi, Sian Yik Lim.
260 $a Singapore : $c 2023. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a x, 118 p. : $b ill., digital ; $c 24 cm.
490 1 $a Tissue repair and reconstruction, $x 2731-9199
505 0 $a Bisphosphonates and Osteonecrosis of the jaw -- Denosumab: Clinical Applications and Outcomes -- Romosozumab: Clinical Outcomes and Outcomes -- Abaloparatide: Clinical Outcomes and its Effects in Bone Regeneration -- Teriparatide: Clinical Outcomes and its Effects in Bone Regeneration.
520 $a This book provides readers a fundamental insight into the basic properties of the pharmaceutical agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated information on clinical utility, and possible side effects associated with the use of these pharmaceutical agents. In particular, it highlights the use of two monoclonal antibodies romosozumab and denosumab in activating osteoblast differentiation and inhibiting osteoclasts. It also discusses two anabolic pharmaceutical agents, teriparatide and abaloparatide to treat osteoporosis. They have been shown to reduce the incidence of non-vertebral and vertebral fractures significantly after they were administered to patients daily as subcutaneous injections. The content of this book caters to researchers, scientists, and clinical practitioners who are interested in the treatment of osteoporosis using pharmaceutical agents.
650 2 4 $a Medicinal Chemistry. $3 668872
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 1366894
650 1 4 $a Biomedical Engineering and Bioengineering. $3 1211019
650 0 $a Osteoporosis $x Chemotherapy. $3 1430666
700 1 $a Lim, Sian Yik. $3 1430665
700 1 $a Choi, Andy H. $3 1229089
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a Tissue repair and reconstruction. $3 1430117
856 4 0 $u https://doi.org/10.1007/978-981-99-5826-9
950 $a Medicine (SpringerNature-11650)